Erbitux 5 mg/mL solution for infusion
10949
Phase 2 small_molecule active
Quick answer
Erbitux 5 mg/mL solution for infusion for Unknown primary tumour of the head and neck is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Unknown primary tumour of the head and neck
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active